Validation experiment designed to validate causal mechanisms targeting Nrf2 in LPS-induced SALI mouse model. Primary outcome: histological damage, pulmonary edema, inflammatory cell infiltration
This experiment investigated the protective effects of acteoside, a plant-derived phenylethanoid glycoside, against sepsis-associated acute lung injury (SALI) using an LPS-induced mouse model. The study examined whether acteoside could alleviate lung injury by targeting ferroptosis, an iron-dependent cell death process. Researchers evaluated histological changes, pulmonary edema, inflammatory cell infiltration, and various biomarkers of inflammation and ferroptosis. The experiment involved treating mice with LPS to induce SALI, followed by acteoside administration, and then assessing lung tissue damage, inflammatory mediator levels (TNF-α, IL-6, IL-1β, IFN-β), and ferroptosis-related parameters including antioxidant enzyme activities (SOD/GSH), oxidative stress markers (iron, GSSG, 4-HNE, MDA), and expression of key ferroptosis-related proteins (SLC7A11, GPX4, Nrf2, ACSL4, TfR1, PTGS2).
LPS injection to induce SALI, acteoside treatment, histological analysis, measurement of inflammatory mediators, assessment of ferroptosis biomarkers
acteoside reduces lung injury, inflammation, and ferroptosis markers
reduced histological damage, decreased inflammatory mediators, improved antioxidant status, normalized ferroptosis-related protein expression
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.